Clinical Report: Vaccines May Do More for Aging Bodies

Overview

Vaccination in older adults protects against specific diseases and offers significant off-target benefits, including reduced risks of dementia and cardiovascular issues. Despite these advantages, vaccination rates among older adults remain suboptimal.

Background

Vaccination is crucial for older adults, who face heightened risks from infectious diseases due to weakened immune systems and chronic illnesses. Recent studies have highlighted additional benefits of vaccines, suggesting they may play a role in promoting healthy aging and preventing cognitive decline. Understanding these off-target benefits is essential for improving vaccination uptake in this vulnerable population, as evidenced by various studies linking vaccination to reduced dementia and cardiovascular risks.

Data Highlights

Key Findings

• Vaccination against shingles is associated with a lower risk of dementia, with studies showing a 20% decline in dementia rates among vaccinated individuals.
• RSV vaccination can reduce hospitalization risk by nearly 70% in the year of vaccination.
• Flu vaccination is linked to lower risks of heart attack and stroke in older adults, with substantial evidence supporting these claims.
• Recent studies suggest potential cardiovascular benefits from RSV vaccination, although more research is needed.
• Only about 31% of older adults have received a flu shot, and vaccination rates for RSV are similarly low, highlighting the need for increased awareness.

Clinical Implications

Healthcare providers should emphasize the importance of vaccinations for older adults, not only for disease prevention but also for their potential off-target benefits. Strategies to increase awareness and address barriers to vaccination, such as educational campaigns and accessibility improvements, can help improve health outcomes in this population.

Conclusion

Vaccines are vital tools for promoting healthy aging in older adults, offering benefits that extend beyond infection prevention. Enhanced vaccination efforts, including addressing barriers to access and increasing public awareness, are necessary to fully realize these advantages.

References

1. CDC, CDC, 2024 -- Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations
2. CDC, CDC -- Shingles Vaccine Recommendations | Shingles (Herpes Zoster)
3. Conexiant, Conexiant -- Shingles Vaccine Tied to Slower Aging
4. Frontiers in Immunology, Frontiers in Immunology -- Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study
5. The Journal of Infectious Diseases, The Journal of Infectious Diseases -- High-Dose Inactivated Influenza Vaccine Inconsistently Improves Heterologous Antibody Responses in an Older Human Cohort
6. The ASCO Post — Breast Cancer Vaccines Moving Forward at a Fast Clip
7. CDC Shingles Vaccine Recommendations
8. CDC RSV Vaccine Recommendations